NHL

Law Firm of Cerri, Boskovich & Allard Files a Lawsuit Over the Alleged Sexual Abuse of a San Jose Jr. Sharks Hockey Player

Retrieved on: 
Thursday, March 7, 2024

The law firm of Cerri, Boskovich & Allard has filed a lawsuit alleging that a San Jose Jr.

Key Points: 
  • The law firm of Cerri, Boskovich & Allard has filed a lawsuit alleging that a San Jose Jr.
  • Sharks hockey player was sexually abused due to the negligence of Sharks Sports & Entertainment, LLC and its subsidiary, Sharks Ice, LLC.
  • Sharks Sports and Entertainment is a privately held company that owns the San Jose Sharks and several sports-related properties throughout the Bay Area.
  • Whitmer, the lawsuit claims, would take the young victim alone into the locker room at Sharks Ice, the ice-skating facility and the official training facility of the NHL's San Jose Sharks.

Melbourne Cricket Club Takes Evolv Technology Down Under

Retrieved on: 
Wednesday, March 6, 2024

Evolv Technology (NASDAQ: EVLV), the leading security technology company pioneering AI-based screening to create safer experiences, today announced its partnership with Melbourne Cricket Club (MCC), the largest – and one of the oldest - sports clubs in Australia.

Key Points: 
  • Evolv Technology (NASDAQ: EVLV), the leading security technology company pioneering AI-based screening to create safer experiences, today announced its partnership with Melbourne Cricket Club (MCC), the largest – and one of the oldest - sports clubs in Australia.
  • Managed by Melbourne Cricket Club, Melbourne Cricket Ground is a sports stadium in Yarra Park, Melbourne, Victoria.
  • Melbourne Cricket Club was introduced to Evolv by Convergint, which supplies Melbourne Cricket Ground with its other security technology.
  • “We were looking for a more efficient entry experience for guests coming to the Melbourne Cricket Ground,” said Rey Sumaru, general manager of IT & innovation for the Melbourne Cricket Club.

Innate Pharma: First Patient dosed in Phase 1/2 study of IPH6501 in relapsed /refractory B-Cell non-Hodgkin’s Lymphoma

Retrieved on: 
Wednesday, March 6, 2024

Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”) today announced the first patient was dosed in its Phase 1/2 multicenter trial ( NCT06088654 ), investigating the safety and tolerability of IPH6501 in patients with Relapsed and/or Refractory CD20-expressing B-cell Non-Hodgkin’s Lymphoma (NHL).

Key Points: 
  • Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”) today announced the first patient was dosed in its Phase 1/2 multicenter trial ( NCT06088654 ), investigating the safety and tolerability of IPH6501 in patients with Relapsed and/or Refractory CD20-expressing B-cell Non-Hodgkin’s Lymphoma (NHL).
  • The study is planned to enroll up to 184 patients.
  • “We are pleased to announce the dosing of a first patient in this Phase 1/2 study evaluating IPH6501, our proprietary ANKET® asset and the first tetraspecific NK Cell Engager to enter the clinic.” commented Dr Sonia Quaratino, Chief Medical Officer at Innate Pharma.
  • In this context, IPH6501 represents an innovative option for the treatment of patients with R/R B-cell non-Hodgkin’s lymphomas and has the potential to fulfil a large unmet need.”

Evolv Technology and Footprint Center Announce Partnership

Retrieved on: 
Tuesday, March 5, 2024

Evolv Technology (NASDAQ: EVLV), the leading security technology company pioneering AI-based weapons detection to create safer experiences, today announced a partnership with Footprint Center to use its state-of-the-art Evolv Express ® screening solution.

Key Points: 
  • Evolv Technology (NASDAQ: EVLV), the leading security technology company pioneering AI-based weapons detection to create safer experiences, today announced a partnership with Footprint Center to use its state-of-the-art Evolv Express ® screening solution.
  • “We are excited to partner with Footprint Center to achieve a more sophisticated security posture and elevated fan experience,” said John Baier, Evolv’s vice president of sports.
  • Footprint Center, home of the Phoenix Suns and Phoenix Mercury, is one of the first NBA arenas to use Evolv Technology, integrated during the start of the 2023-24 season.
  • Footprint Center joins a growing roster of facilities and sports teams using Evolv Technology for weapons detection .

Brightcove to Power MotoAmerica’s First Global Livestream of the Daytona 200

Retrieved on: 
Tuesday, March 5, 2024

As the official streaming provider for MotoAmerica, Brightcove will power the live and video-on-demand (VOD) capabilities of the MotoAmerica Live+ streaming service, which will exclusively broadcast the upcoming 82nd running of the Daytona 200 (March 7-9, 2024).

Key Points: 
  • As the official streaming provider for MotoAmerica, Brightcove will power the live and video-on-demand (VOD) capabilities of the MotoAmerica Live+ streaming service, which will exclusively broadcast the upcoming 82nd running of the Daytona 200 (March 7-9, 2024).
  • “Delivering quality live and on-demand streaming experiences is essential for today’s sports and entertainment organizations to reach and engage their audiences effectively,” said Marc DeBevoise, CEO of Brightcove.
  • “In response, we decided to collaborate with Brightcove to offer our fans the upgraded experience they have been asking for.
  • Partnering with Brightcove ensures that both current and new fans of MotoAmerica can enjoy the best viewing experience possible.

johnnie-O Announces the Launch of the Brand’s First-Ever Women’s Capsule Collection

Retrieved on: 
Friday, March 1, 2024

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20240301149652/en/
    johnnie-O announces the launch of the brand's first-ever women's capsule collection.
  • (Photo: Business Wire)
    The women’s capsule collection has been thoughtfully curated to blend comfort with everyday essentials through various styles, including transitional dresses, on-trend matching sets, and luxuriously soft sweaters.
  • The capsule collection embodies the laid-back johnnie-O spirit while bringing timeless style to luxe pieces, from garment-washed French terry to ultra-soft knits and wovens.
  • The brand also recently launched an NHL Collection for men and boys, in addition to its MLB Collection, NCAA Collegiate Collection, and select PGA Tour and USGA Golf Tournament Collections.

SeatGeek Announces Next Fan Up Product Release Ahead of MLB Season

Retrieved on: 
Monday, February 26, 2024

In anticipation of the MLB season, SeatGeek is introducing Next Fan Up , its new product release that reimagines the ticket-selling experience.

Key Points: 
  • In anticipation of the MLB season, SeatGeek is introducing Next Fan Up , its new product release that reimagines the ticket-selling experience.
  • (Graphic: Business Wire)
    A fall 2023 SeatGeek survey of season ticket members found that 45% were concerned about having paid for games they wouldn’t be able to attend.
  • “Our goal for Next Fan Up is to make the ticket-selling experience easier,” said Russ D'Souza, co-founder of SeatGeek.
  • “Working with SeatGeek has opened up new avenues for us to enhance the fan experience, and fan selling is a part of that.

Evolv Technology Corrects Misinformation about the Company

Retrieved on: 
Tuesday, February 20, 2024

Evolv Technology was founded in 2013 as a next-generation physical security company committed to making the world a safer place.

Key Points: 
  • Evolv Technology was founded in 2013 as a next-generation physical security company committed to making the world a safer place.
  • Over the past year, Evolv believes it has been the target of a short seller campaign, coordinating with certain media outlets, who are incentivized to discredit the company, misrepresent facts, and promote misinformation.
  • Evolv is committed to our mission of making the world safer and stands behind our technology as vetted by hundreds of security professionals in real world environments.
  • Evolv is upfront about the tradeoffs and customers regularly call out this as a key source of trust in Evolv and across the Evolv customer community.

ESPN+ NOW AVAILABLE TO CHARTER'S SPECTRUM TV SELECT PLUS CUSTOMERS AT NO EXTRA COST

Retrieved on: 
Thursday, March 7, 2024

STAMFORD, Conn. and BURBANK, Calif., March 7, 2024 /PRNewswire/ -- Charter Communications, Inc. and The Walt Disney Company today announced ESPN+ is now available to Spectrum TV Select Plus customers at no additional cost, as the two companies' industry-leading distribution agreement from 2023 continues to benefit consumers by making streaming apps part of linear Spectrum TV bundle packages.

Key Points: 
  • The availability of ESPN+, which currently retails for $10.99 per month, comes after Charter and The Walt Disney Company in January made the Disney+ Basic streaming app available to all Spectrum TV Select customers nationwide at no extra cost.
  • New and existing Spectrum TV Select Plus customers can learn more about how to activate their ESPN+ subscription at no additional cost at spectrum.com/espn+ .
  • TV Select Plus offers all of the programming available through TV Select Signature, plus additional sports channels including Regional Sports Networks and national networks such as MLB Network, NBA TV and NFL Network, for an additional $10 per month.
  • TV Select Plus customers who already have Disney+ as part of their Spectrum service can use their Disney+ account credentials so that both subscriptions are under one account.

Tampa General Hospital Brings New Hope for Patients with Advanced Blood Cancers

Retrieved on: 
Monday, March 4, 2024

TAMPA, Fla., March 4, 2024 /PRNewswire/ -- As part of its commitment to harness innovative advances in cancer care, the Tampa General Hospital (TGH) Cancer Institute has added a novel approach to its therapeutic armamentarium for the treatment of patients with aggressive forms of B-cell non-Hodgkin lymphomas and other types of blood cancers.

Key Points: 
  • The field of immunotherapy has evolved from an academic research program to an essential pillar in the treatment of many cancers.
  • All are intended for the treatment of blood cancers, including lymphomas, some forms of leukemia and, most recently, multiple myeloma.
  • Following comprehensive planning and discussion, Tampa General's Hospital at Home program has started to be applied to CAR T patients meeting certain criteria.
  • Due the benefit of remote monitoring, the TGH Cancer Institute and Hospital at Home teams have been working on adapting Hospital at Home for oncology patients.